MSD global restructure turns to France, with manufacturing site set for sale
MSD is looking to sell its Riom site that specializes in the manufacture of sterile drugs, as part of the company’s overall restructure.
Archives for November 14, 2019
CPhI Worldwide 2019
Early monitoring key to countering variability in bioproduction
Regardless of the quality of the raw materials used in bioproduction processes, variability is a very common threat that can be addressed, says Thermo Fisher executive.
Dupixent drives up Regeneron spending on contract manufacturing
Regeneron Pharmaceuticals increases spending on collaboration and contract manufacturing by 39% on rising Dupixent sales.
Intercept activates contract sales force to support NASH drug launch
Intercept Pharmaceuticals prepares to introduce NASH drug onto the market by hiring a contract sales team.